BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 1322795)

  • 21. Epidermal growth factor receptor is not amplified in schwannomas.
    Prayson RA; Yoder BJ; Barnett GH
    Ann Diagn Pathol; 2007 Oct; 11(5):326-9. PubMed ID: 17870017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas.
    Viana-Pereira M; Lopes JM; Little S; Milanezi F; Basto D; Pardal F; Jones C; Reis RM
    Anticancer Res; 2008; 28(2A):913-20. PubMed ID: 18507036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
    Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
    Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
    J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplification of the epidermal growth factor receptor gene in human gliomas.
    Torp SH; Helseth E; Ryan L; Stølan S; Dalen A; Unsgaard G
    Anticancer Res; 1991; 11(6):2095-8. PubMed ID: 1776845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplified genes in human gliomas.
    Collins VP
    Semin Cancer Biol; 1993 Feb; 4(1):27-32. PubMed ID: 8448375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
    Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
    Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth factors and oncogenes in human malignant glioma.
    Westermark B; Nister M; Heldin CH
    Neurol Clin; 1985 Nov; 3(4):785-99. PubMed ID: 3001490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
    Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
    Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
    Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A
    Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
    Miyanaga T; Hirato J; Nakazato Y
    Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.
    Arakawa Y; Tachibana O; Hasegawa M; Miyamori T; Yamashita J; Hayashi Y
    Acta Neuropathol; 2005 Mar; 109(3):294-8. PubMed ID: 15627206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
    Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
    Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
    Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor receptor expression in oligodendroglial tumors.
    Reifenberger J; Reifenberger G; Ichimura K; Schmidt EE; Wechsler W; Collins VP
    Am J Pathol; 1996 Jul; 149(1):29-35. PubMed ID: 8686753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
    Coltrera MD; Wang J; Porter PL; Gown AM
    Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption.
    Liau LM; Lallone RL; Seitz RS; Buznikov A; Gregg JP; Kornblum HI; Nelson SF; Bronstein JM
    Cancer Res; 2000 Mar; 60(5):1353-60. PubMed ID: 10728698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.
    Ivliev AE; 't Hoen PA; Sergeeva MG
    Cancer Res; 2010 Dec; 70(24):10060-70. PubMed ID: 21159630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines.
    Bax DA; Gaspar N; Little SE; Marshall L; Perryman L; Regairaz M; Viana-Pereira M; Vuononvirta R; Sharp SY; Reis-Filho JS; Stávale JN; Al-Sarraj S; Reis RM; Vassal G; Pearson AD; Hargrave D; Ellison DW; Workman P; Jones C
    Clin Cancer Res; 2009 Sep; 15(18):5753-61. PubMed ID: 19737945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.